MRCA Pharmaceutical Benefits Scheme (No. MRCC 44/2013)
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
MRCA Pharmaceutical Benefits Scheme (No. MRCC 44/2013)
Start here
Turn the raw legal text into a practical explanation grounded in MRCA Pharmaceutical Benefits Scheme (No. MRCC 44/2013).
45 Keeping documents‑other than for continued dispensing or medication chart prescriptions
(1) If a Community Pharmacist supplies a Pharmaceutical benefit, other than a Pharmaceutical benefit that is:
(a) a dangerous drug (defined below); or
(b) supplied under section 16A (continued dispensing); or
(c) supplied on the basis of a medication chart prescription;
the Community Pharmacist must keep a document specified in subsection (2) that relates to the supply for at least 2 years after the supply.
(2) For subsection (1), the following documents are specified:
(a) in the case of supply upon a prescription not bearing instructions to supply the Pharmaceutical benefit more than once:
(i) for a paper‑based prescription—the pharmacist/patient copy and the Medicare Australia/DVA copy; or
(ii) for an electronic prescription—the electronic prescription, or a copy of the electronic prescription;
(ab) in the case of supply upon a prescription bearing instructions to supply the Pharmaceutical benefit more than once, if it is supplied on the first occasion on which supply is authorised:
(i) for a paper‑based prescription—the Medicare Australia/DVA copy; or
(ii) for an electronic prescription—the electronic prescription, or a copy of the electronic prescription and the repeat authorisation;
(ac) in the case of supply upon a prescription bearing instructions to supply the Pharmaceutical benefit more than once, if it is supplied other than on the first or last occasion on which supply is authorised:
(i) for a paper‑based prescription—the repeat authorisation for the most recent previous supply; or
(ii) for an electronic prescription—the electronic prescription, or a copy of the electronic prescription and the repeat authorisation for the most recent previous supply;
(b) in the case of supply upon a prescription bearing instructions to supply the Pharmaceutical benefit more than once, if it is supplied on the last occasion on which supply is authorised:
(i) for a paper‑based prescription—the pharmacist/patient copy and the repeat authorisation for the most recent previous supply; or
(ii) for an electronic prescription—the electronic prescription, or a copy of the electronic prescription and the repeat authorisation for the most recent previous supply;
Note: The document may be kept in an electronic form (see subsection 12(2) of the Electronic Transactions Act 1999).
(3) In this section:
dangerous drug means a drug or medicinal preparation in respect of which the law of the State or Territory in which the prescription is written provides that a pharmacist who dispenses that drug or medicinal preparation, or who dispenses it on the last of a number of occasions of supply indicated in a prescription for its supply, must take possession of the prescription and cancel it or deliver it to the authority administering that law.